A consecutive alternative analysis has been carried out of clinical, immunogenetic and immunological indices in patients with primary erysipelas of the lower extremities with and no recurrences during the last 3-5 years. The authors compiled a special scale allowing precise and early prediction of unfavourable, recurrent course of primary erysipelas of the lower extremities.

Download full-text PDF

Source

Publication Analysis

Top Keywords

erysipelas lower
12
clinical immunogenetic
8
immunogenetic immunological
8
immunological indices
8
primary erysipelas
8
lower extremities
8
[the clinical
4
indices predicting
4
predicting development
4
development recurrent
4

Similar Publications

A 13-year-old female with a history of congenital left lower leg lymphedema, multiple food allergies, including an immunoglobulin E mediated severe cow's milk allergy, and well-controlled moderate persistent asthma was hospitalized with left lower leg erysipelas and Group A Streptococcus septicemia. While hospitalized, immediately after exposure to cow's milk protein as an inactive ingredient within a probiotic, she developed anaphylaxis with respiratory failure requiring intubation. This is only the third reported case of anaphylaxis due to a probiotic.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates the adverse drug events (ADEs) linked to TNF-α inhibitors (TNFis) used in rheumatoid arthritis (RA) patients, pulling data from the FDA's reporting system to enhance clinical understanding.
  • - Four common ADEs among TNFis are identified (pulmonary tuberculosis, infections, hypersensitivity, and herpes zoster), but each TNFi also has unique ADEs: Adalimumab has the highest with 63 unique events, while etanercept has 180 unique ADEs.
  • - The research highlights the need for careful medication selection by clinicians, especially for RA patients with existing malignancies, due to the variety of common and unique ADEs linked to different TNFis.
View Article and Find Full Text PDF
Article Synopsis
  • Obesity and chronic oedema/lymphoedema are related conditions, with this study exploring how increased weight affects chronic oedema in patients with leg swelling.
  • The study surveyed 7,397 patients across 38 centers in nine countries, revealing that heavier patients experienced more severe stages of chronic oedema compared to those with normal weight.
  • Ten independent factors were linked to increased weight, including diabetes and decreased mobility, suggesting that obesity worsens chronic oedema control and decreases overall quality of life.
View Article and Find Full Text PDF

[Evidence of modern diagnostic, conservative, and surgical therapy of secondary lymphoedema].

Handchir Mikrochir Plast Chir

August 2024

Klinik für Plastische Chirurgie, Hand- und Rekonstruktive Mikrochirurgie, Handtrauma- und Replantationszentrum, BG Unfallklinik Frankfurt am Main, Frankfurt am Main, Germany.

Article Synopsis
  • Secondary lymphoedema (SL) is a common complication of cancer treatment, requiring careful diagnosis through techniques like MR lymphography and ICG lymphography for effective management.
  • The systematic review highlights the superiority of complex physical decongestion therapy (CPE) over other methods and demonstrates the positive outcomes of (super)microsurgical techniques in reducing symptoms and improving quality of life.
  • Ongoing conservative therapy and regular re-evaluation are crucial for patients with SL, particularly those at high risk or experiencing worsening symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • * The paper details four unique cases of common infectious skin conditions with atypical presentations, highlighting challenges in diagnosis despite their prevalence.
  • * It emphasizes the need for aggressive treatment and awareness of risk factors and pathophysiology, suggesting that these conditions should be taken seriously by clinicians.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!